Calton & Associates’s NutriSystem, Inc. NTRI Stock Holding History

Calton & Associates’s Portfolio NTRI Stock Details NTRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100	Closed	-$4K	–	1461
2017 Q4	$4K	Buy	+100	New	+$5.25K	﹤0.01%	1301

Other funds holding NTRI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Calton & Associates's NTRI Position: Q1 2018 in Review

Calton & Associates sold out of NutriSystem, Inc. (NTRI) in Q1 2018, closing a stake of 100 shares — an estimated $4K sold.

Calton & Associates first reported a position in NTRI in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 218 funds tracked by Wall St. Rank hold NTRI as of Q1 2018.

Calton & Associates reported no remaining NutriSystem, Inc. position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 100 NutriSystem, Inc. shares in Q1 2018, an estimated $4K.
Calton & Associates first reported a position in NutriSystem, Inc. in Q4 2017 and held it in 1 quarter.
Calton & Associates's NutriSystem, Inc. position peaked at $4K in Q4 2017.
218 funds tracked by Wall St. Rank held NutriSystem, Inc. as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.